Figure 4.
Incidence of toxicities with respect to number of lines of therapy. Cumulative incidence of febrile neutropenia (A), oral/GI (B), infections (C), and cardiovascular toxicities (D) with respect to the number of lines of therapy.
Incidence of toxicities with respect to number of lines of therapy. Cumulative incidence of febrile neutropenia (A), oral/GI (B), infections (C), and cardiovascular toxicities (D) with respect to the number of lines of therapy.